Skip to main content
. 2024 Dec 19;17:6367–6376. doi: 10.2147/IJGM.S496996

Table 5.

Comparison of Adverse Reactions

Adverse Reactions Control (n=51) Observation (n=52) P
Dizziness and Nausea 3 (5.88%) 4 (7.69%)
Hypotension 3 (5.88%) 2 (3.85%)
Hyperkalemia 2 (3.92%) 1 (1.92%)
Renal Function Changes 1 (1.96%) 1 (1.92%)
Bradycardia 1 (1.96%) 0 (0.00%)
Total Incidence 10 (19.61%) 8 (15.38%) 0.318 0.572